One trial, SIGMA, will evaluate Grifols’ intravenous immunoglobulin (Ig) GAMUNEX ® -C (immune globulin injection [human], 10% caprylate ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise MRD™, broadening availability to patients ...

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty ...

These poster/oral presentations took place between 27 th –30 th May 2026, as part of the European Association for the Study of the Liver (EASL) Congress held in Barcelona, Spain Sood has received ...

Plasma exchange can help treat people with a rare inflammatory disease that can cause blindness, according to a systematic ...

I was diagnosed with relapsing-remitting multiple sclerosis (RRMS) at the age of 46.

The novel TRM-SLE nephropathy domain was associated with long-term lupus nephritis outcomes and might be used to enroll patients in trials. Proteinuria alone is an unreliable guide for treatment ...

Gilead Sciences, Inc. today announced its upcoming participation in the 26th International AIDS Conference (AIDS 2026) taking place in Rio de Janeiro, Brazil, from July 26-31. As a leader in HIV ...